Llwytho...
Rapid Infliximab Infusion in Children with Inflammatory Bowel Disease: A Multicenter North American Experience
BACKGROUND: Infliximab (IFX) infusion may lead to development of anti-IFX antibodies, and subsequent infusion reactions (IRs). The safety of rapid IFX infusion administered over 60 minutes has been under-investigated in children with inflammatory bowel disease. In a multicenter study, the frequency...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Inflamm Bowel Dis |
|---|---|
| Prif Awduron: | , , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6551232/ https://ncbi.nlm.nih.gov/pubmed/29140940 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MIB.0000000000001259 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|